Use of computational software in drug research is growing, and some big tech companies are angling for a piece of this market. Cadence Design Systems is entering the life sciences sector through the $500 million acquisition of OpenEye Scientific, a company that provides computational drug design software to the pharmaceutical industry.
In a challenge where researchers try to predict the shape of newly identified proteins, an AI system developed by DeepMind determined the shape of two-thirds of proteins with an accuracy comparable to laboratory experiments.
There are a number of criteria for selecting the best autism therapy centers. Parents choosing a facility or professionals seeking to improve their offerings should consider certain standards to ensure the right fit.
HealthMode's goal is to get cough data from a 1,000 people and train AI models to ultimately be able to diagnose Covid-19 and perhaps even to predict how severe the disease will be.
A new Nature paper has described a first-of-its-kind mathematical model for predicting how a cancer patient will benefit from checkpoint inhibitors, a class of drugs that includes Merck’s Keytruda and Bristol Myers-Squibb’s Opdivo.
No tool has been able to simultaneously analyze genomic sequencing data for copy number variations, or aneuploidy, in which chromosomes get duplicated and structural rearrangements, such as DNA insertions, deletions, duplications or rearrangements. Until now.